A Spotlight on Sunscreen Regulation

Abstract

There may be nothing new under the sun, but the U.S. Food and Drug Administration (FDA) is facing calls for something new under the agency's authority over sunscreens. In recent months, the FDA has declined to permit use of eight new sunscreen ingredients without additional data, although those ingredients have been used in Europe for more than 5 years and despite the recent passage of a U.S. law intended to expedite the marketing-approval process for new products. The controversy says as much about the challenges facing the agency as it does about sunscreen regulation. Melanoma is a significant public health . . .